🎁
DIWALI SPECIAL

20% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

BLISSGVS vs THEMISMED: Stock Comparison

BLISSGVS vs THEMIS MEDICAREUpdated 2 Jul 26, 4:08 PM ISTNSE & company filings

BLISSGVS is the larger company by market capitalisation. BLISSGVS shows a higher ROE, faster revenue growth and lower leverage, while THEMIS MEDICARE shows a lower P/E and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

BLISSGVS leads 8; THEMISMED leads 3 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

BLISSGVSTHEMISMED

Valuation lens

What price are you paying?

Market CapContext only
₹6,983 Cr
₹910 Cr
P/E RatioTHEMISMED has the lower reading
53.03x
22.24x ✓
P/B RatioTHEMISMED has the lower reading
6.05x
2.23x ✓
EPSBLISSGVS has the higher reading
₹4.72 ✓
₹2.67
Book ValueContext only
₹116.14
₹43.28
Dividend YieldTHEMISMED has the higher reading
0.22%
0.52% ✓

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
BLISSGVS is the larger company
₹6,983 Cr vs ₹910 Cr
P/E Ratio
THEMISMED has a lower P/E
22.24x vs 53.03x
P/B Ratio
THEMISMED has a lower P/B
2.23x vs 6.05x
EPS
BLISSGVS has higher earnings per share
₹4.72 vs ₹2.67
Dividend Yield
THEMISMED has a higher dividend yield
0.52% vs 0.22%
Revenue Growth (TTM YoY)
BLISSGVS has faster revenue growth
29.8% vs 6.7%
EPS Growth (TTM YoY)
BLISSGVS has faster EPS growth
124.7% vs 0%
ROE
BLISSGVS has a higher ROE
10.94% vs 0.29%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBLISSGVSTHEMISMED
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricBLISSGVSTHEMISMED
Live Price₹527.1₹98.78
Day Change0.68%1.29%
Volume3.93 L15,306
52-Week High₹553₹140.6
52-Week Low₹118₹64.95
Distance from 52W High-4.68%-29.74%

Valuation

MetricBLISSGVSTHEMISMED
Market Cap₹6,983 Cr₹910 Cr
P/E Ratio53.03x22.24x
P/B Ratio6.05x2.23x
EPS₹4.72₹2.67
Book Value₹116.14₹43.28
Dividend Yield0.22%0.52%

Growth

MetricBLISSGVSTHEMISMED
Revenue Growth (TTM YoY)29.8%6.7%
EPS Growth (TTM YoY)124.7%0%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricBLISSGVSTHEMISMED
ROE10.94%0.29%
ROCE13.83%-0.27%
Net Margin13.93%0.33%
Operating Margin21.74%-0.42%
Debt to Equity0x0.25x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricBLISSGVSTHEMISMED
Promoter Holding50.07%▲ 15.06 pp57.5%
FII Holding5.03%▼ 3.04 pp0.01%
DII Holding9.62%▲ 0.15 pp0.01%
Public Holding35.28%▼ 12.17 pp32.87%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: BLISSGVS and THEMIS MEDICARE.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.